全文获取类型
收费全文 | 2182877篇 |
免费 | 160751篇 |
国内免费 | 4716篇 |
专业分类
耳鼻咽喉 | 28521篇 |
儿科学 | 71836篇 |
妇产科学 | 58790篇 |
基础医学 | 317662篇 |
口腔科学 | 63590篇 |
临床医学 | 196972篇 |
内科学 | 423924篇 |
皮肤病学 | 49640篇 |
神经病学 | 166205篇 |
特种医学 | 81694篇 |
外国民族医学 | 316篇 |
外科学 | 329130篇 |
综合类 | 49814篇 |
现状与发展 | 5篇 |
一般理论 | 663篇 |
预防医学 | 161895篇 |
眼科学 | 52197篇 |
药学 | 161198篇 |
9篇 | |
中国医学 | 6146篇 |
肿瘤学 | 128137篇 |
出版年
2021年 | 16597篇 |
2019年 | 17279篇 |
2018年 | 25128篇 |
2017年 | 19235篇 |
2016年 | 21123篇 |
2015年 | 23905篇 |
2014年 | 33071篇 |
2013年 | 48553篇 |
2012年 | 66702篇 |
2011年 | 70291篇 |
2010年 | 41660篇 |
2009年 | 38992篇 |
2008年 | 65231篇 |
2007年 | 69584篇 |
2006年 | 70059篇 |
2005年 | 66829篇 |
2004年 | 64563篇 |
2003年 | 61409篇 |
2002年 | 59113篇 |
2001年 | 114092篇 |
2000年 | 116241篇 |
1999年 | 95950篇 |
1998年 | 25121篇 |
1997年 | 21788篇 |
1996年 | 22002篇 |
1995年 | 21227篇 |
1994年 | 19479篇 |
1993年 | 17940篇 |
1992年 | 72513篇 |
1991年 | 70732篇 |
1990年 | 68068篇 |
1989年 | 65780篇 |
1988年 | 59963篇 |
1987年 | 58325篇 |
1986年 | 55193篇 |
1985年 | 52089篇 |
1984年 | 38376篇 |
1983年 | 32609篇 |
1982年 | 18243篇 |
1979年 | 34001篇 |
1978年 | 23683篇 |
1977年 | 20062篇 |
1976年 | 18891篇 |
1975年 | 20100篇 |
1974年 | 24082篇 |
1973年 | 23198篇 |
1972年 | 21700篇 |
1971年 | 20041篇 |
1970年 | 18840篇 |
1969年 | 17527篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Hannah C. Nordhues Anjali Bhagra Natya N. Stroud Jennifer A. Vencill Carol L. Kuhle 《Mayo Clinic proceedings. Mayo Clinic》2021,96(7):1907-1920
The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and health burdens along with overlapping vulnerabilities related to the pandemic. In addition, this review outlines recommended strategies that advocacy groups, community leaders, and policymakers should implement to mitigate the widening gender disparities related to COVID-19. 相似文献
12.
13.
IntroductionHip displacement is common in cerebral palsy (CP) and is related to the severity of neurological and functional impairment. It is a silent, but progressive disease, and can result in significant morbidity and decreased quality of life, if left untreated. The pathophysiology of hip displacement in CP is a combination of hip flexor-adductor muscle spasticity, abductor muscle weakness, and delayed weight-bearing, resulting in proximal femoral deformities and progressive acetabular dysplasia. Due to a lack of symptoms in the early stages of hip displacement, the diagnosis is easily missed. Awareness of this condition and regular surveillance by clinical examination and serial radiographs of the hips are the key to early diagnosis and treatment.Hip surveillance programmesSeveral population-based studies from around the world have demonstrated that universal hip surveillance in children with CP allows early detection of hip displacement and appropriate early intervention, with a resultant decrease in painful dislocations. Global hip surveillance models are based upon the patients’ age, functional level determined by the Gross Motor Function Classification system (GMFCS), gait classification, standardized clinical exam, and radiographic indices such as the migration percentage (MP), as critical indicators of progressive hip displacement.ConclusionDespite 25 years of evidence showing the efficacy of established hip surveillance programmes, there is poor awareness among healthcare professionals in India about the importance of regular hip surveillance in children with CP. There is a need for professional organizations to develop evidence-based guidelines for hip surveillance which are relevant to the Indian context. 相似文献
14.
15.
16.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
17.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
18.
19.
Clinical & Experimental Metastasis - 相似文献
20.